Oral ibandronate produces significant antifracture efficacy when given intermittently with a between-dose interval of >2 months

被引：0

作者：

Felsenberg, D

Halse, J

Skag, A

Gilbride, J

Schimmer, RC

机构：

[1] Univ Klinikum Benjamin Franklin, Osteoporose Forschungsgrp, Berlin, Germany

[2] Osteoporoseklinikken, Oslo, Norway

[3] Ctr Clin Trials, Paradis, Norway

[4] F Hoffmann La Roche Ltd, Basel, Switzerland

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：97 / 97

页数：1

共 3 条

Oral ibandronate produces significant antifracture efficacy when given intermittently with a between-dose interval of &gt;2 months